Suppr超能文献

一种靶向金黄色葡萄球菌群体感应通路的模拟表位疫苗的研发。

Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.

作者信息

O'Rourke John P, Daly Seth M, Triplett Kathleen D, Peabody David, Chackerian Bryce, Hall Pamela R

机构信息

Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States of America.

Department of Pharmaceutical Sciences, University of New Mexico School of Medicine, Albuquerque, NM United States of America.

出版信息

PLoS One. 2014 Nov 7;9(11):e111198. doi: 10.1371/journal.pone.0111198. eCollection 2014.

Abstract

A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.

摘要

疫苗研发中的一个主要障碍是难以识别相关的靶表位,然后以模拟其天然构象的方式将它们呈递给免疫系统。我们设计了一种新型病毒样颗粒(VLP)技术,该技术能够在衣壳蛋白表面暴露的环上展示随机肽序列的复杂文库,而不会破坏蛋白质折叠或VLP组装。这项技术使我们能够将同一个VLP颗粒用于亲和力选择和免疫接种,将传统噬菌体展示的表位发现和表位模拟能力与VLP的高免疫原性结合起来。此前,我们表明使用我们的VLP平台进行亲和力选择可识别单克隆抗体的线性表位,随后的免疫接种可产生适当的抗体反应。为了测试我们的技术是否能够识别免疫模拟表位,我们对识别金黄色葡萄球菌自诱导肽4(AIP4)的单克隆抗体(AP4-24H11)进行了亲和力选择。AIP4是一种由金黄色葡萄球菌辅助基因调节因子(agrIV)群体感应操纵子产生的分泌型八氨基酸环化肽。agr系统协调基因表达中密度依赖性变化,导致许多毒力因子上调,并且AP4-24H11的被动转移可预防金黄色葡萄球菌agrIV依赖性致病性。在本报告中,我们鉴定了一组展示在VLP上的肽,它们与AP4-24H11具有高特异性结合。重要的是,与用AP4-24H11进行被动转移类似,用这些VLP的一个子集进行免疫接种可在金黄色葡萄球菌皮肤坏死小鼠模型中预防致病性。这些数据证明了这样一个原理,即通过对中和抗体进行亲和力选择,我们的VLP技术可以识别非线性表位的肽模拟物,并且这些基于模拟表位的VLP疫苗在相关动物模型中可提供针对病原体的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056a/4224382/e2e5e6776500/pone.0111198.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验